Evenity (Romosozumab) Accelerated Titration: What the Evidence Actually Shows
Romosozumab (Evenity) uses a fixed 210 mg monthly dose for 12 months with no titration. Learn why dose escalation doesn't apply, what the ARCH and FRAME trials found, and how clinicians sequence this sclerostin inhibitor for high-risk osteoporosis.
Read clinical review